| Schedule of Share-Based Payment Arrangement, Option, Activity |
The following table summarizes information regarding stock option and RSU activity in the Inducement Equity Incentive Plan (the “Inducement EIP”) during the six months ended June 30, 2026 (in thousands, except per share data and weighted average contractual life): | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | Number of Stock Options | | Weighted- Average Exercise Price | | Weighted-Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value | | Outstanding, January 1, 2026 | 108 | | | $ | 7.47 | | | 9.7 | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding, June 30, 2026 | 108 | | | $ | 7.47 | | | 9.2 | | $ | — | | | | | | | | | | | Expected to vest as of June 30, 2026 | 108 | | | $ | 7.47 | | | 9.2 | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | RSUs | Number of RSUs | | Weighted- Average Grant Date Fair Value per Share | | Weighted-Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value | Outstanding, January 1, 2026 | 220 | | | $ | 6.25 | | | 2.9 | | $ | 895 | | | | | | | | | | | Outstanding, June 30, 2026 | 220 | | | $ | 6.25 | | | 2.4 | | $ | 895 | | | | | | | | | | | Expected to vest as of June 30, 2026 | 220 | | $ | 6.25 | | | 2.4 | | $ | 895 | |
The following table summarizes information regarding stock option and RSU activity in the 2024 EIP during the six months ended June 30, 2026 (in thousands, except per share data and weighted average contractual life): | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | Number of
Stock Options | | Weighted-
Average
Exercise Price | | Weighted-Average
Remaining
Contractual
Life (years) | | Aggregate Intrinsic Value | Outstanding, January 1, 2026 | 1,116 | | | $ | 2.52 | | | 8.4 | | $ | 3,996 | | Granted | 17 | | | $ | 6.95 | | | | | | Exercised | (119) | | | $ | 2.17 | | | | | | | Forfeited | (78) | | | $ | 3.62 | | | | | | | Outstanding, June 30, 2026 | 936 | | | $ | 2.55 | | | 8.4 | | $ | 1,618 | | | Exercisable as of June 30, 2026 | 638 | | | $ | 2.12 | | | 8.3 | | $ | 1,246 | | | Expected to vest as of June 30, 2026 | 298 | | | $ | 3.48 | | | 8.7 | | $ | 373 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | Number of RSUs | | Weighted- Average Grant Date Fair Value per Share | | Weighted-Average Remaining Contractual Life (years) | | | | Aggregate Intrinsic Value | | Outstanding, January 1, 2026 | — | | | $ | — | | | — | | | | | $ | — | | | Granted | 634 | | | $ | 6.96 | | | | | | | | | Released | (37) | | | $ | 6.95 | | | | | | | | | Forfeited | (21) | | | $ | 6.95 | | | | | | | | | Outstanding, June 30, 2026 | 576 | | | $ | 6.96 | | | 3.3 | | | | $ | 2,316 | | | Exercisable as of June 30, 2026 | — | | | $ | — | | | — | | | | | $ | — | | | Expected to vest as of June 30, 2026 | 576 | | | $ | 6.96 | | | 3.3 | | | | $ | 2,316 | |
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The determination of the fair value of options granted under the Inducement EIP and the 2024 EIP during the six months ended June 30, 2026 was computed using the Black-Scholes option pricing model with the following weighted-average assumptions: | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | | | | | | 2026 | | 2025 | | | | | | | Stock price per share | $ | 6.95 | | | $ | 2.01 | | | | | | | | Expected option term (years) | 5.8 | | 5.5 | | | | | | | Expected volatility | 76.6 | % | | 71.2 | % | | | | | | | Risk-free rate of return | 4.1 | % | | 4.0 | % | | | | | | | Expected annual dividend yield | — | % | | — | % | | | | | | Weighted-average grant date fair value | $ | 6.95 | | | $ | 1.29 | | | | | | |
|
| Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount |
The following table shows stock-based compensation expense by functional area in the unaudited condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Research and development | $ | 77 | | | $ | 11 | | | $ | 107 | | | $ | 28 | | | Selling, general and administrative | 591 | | | 208 | | | 942 | | | 292 | | Total stock-based compensation expense | $ | 668 | | | $ | 219 | | | $ | 1,049 | | | $ | 320 | |
|